EMERYVILLE, Calif.,Oct. 29 /PRNewswire-FirstCall/ -- Bionovo, Inc. announced today that it will release financial results for the third quarter of fiscal year 2009 ended September 30, 2009 on Thursday, November 5, 2009. The Company will conduct a conference call and web cast to review the financial results on Thursday, November 5, 2009 at 4:45 p.m. ET.
About Bionovo, Inc.
Bionovo, Inc. is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the NASDAQ Capital Market under the symbol, "BNVI". For more information about Bionovo and its programs, visit: http://www.bionovo.com.
Bionovo, Inc.
